Literature DB >> 20591228

The Role of GDC Embolization as a Second Choice in the Treatment of Ruptured Cerebral Aneurysm. Retrospective Analysis from Mid-Term Outcome.

H Manabe1, S Hasegawa, A Takemura.   

Abstract

SUMMARY: We investigated the role of GDC embolization as a second choice for the treatment of ruptured cerebral aneurysm. From september 1997 to may 2001, 139 ruptured aneurysms out of 151 consecutive ruptured aneurysms transferred to our hospital were treated by clipping (first choice) or GDC embolization (second choice). Patient selection was decided by more than two neurosurgeons under the policy that GDC embolization is the second choice of treatment. The mid-term (longer than three months) outcome of both group was examined. One hundred and nineteen Ans (BA two, ICparaclinoid one, IC-PC or IC-Ach 36, IC-ant. Wall two, ACoA34, ACA six, MCA38) were treated by clipping (clipping group), 20 Ans (surgical difficulty; BA three, IC-paraclinoid three, VA dissection six, general complications; IC-PC two, IC-dissection one, ACoA four, VAPICA one) by GDC embolization (GDC group) within 24 hours after admission. SAH grade and GOS of each group were Gr1: 35&4, Gr2: 41&5, Gr3: 23&5, Gr4: 11&4, Gr5: 9&2, respectively, and GR: 79&14, MD: 8&3, SD: 11&0, VS: 8&0, D: 13&3 respectively. Good prognosis (better than MD) was gained in 73% of clipping group and 85% of GDC group. No rebleeding was seen in GDC group. GDC embolization for the cases with surgical difficulty or general complication raised the overall outcome. GDC embolization would be suitable for IC-paraclinoid Ans, BA-VA Ans, and ruptured VA dissections. Because of the good clinical outcome gained in the GDC group, GDC treatment would be the first choice of treatment for such aneurysms as geometrically suitable for coiling.

Entities:  

Year:  2004        PMID: 20591228      PMCID: PMC3553477          DOI: 10.1177/15910199030090S104

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  9 in total

1.  Prospective analysis of aneurysm treatment in a series of 103 consecutive patients when endovascular embolization is considered the first option.

Authors:  C Raftopoulos; P Mathurin; D Boscherini; R F Billa; M Van Boven; P Hantson
Journal:  J Neurosurg       Date:  2000-08       Impact factor: 5.115

2.  Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients.

Authors:  F Viñuela; G Duckwiler; M Mawad
Journal:  J Neurosurg       Date:  1997-03       Impact factor: 5.115

Review 3.  Treatment of intracranial aneurysms by embolization with coils: a systematic review.

Authors:  E H Brilstra; G J Rinkel; Y van der Graaf; W J van Rooij; A Algra
Journal:  Stroke       Date:  1999-02       Impact factor: 7.914

4.  The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results.

Authors:  N F Kassell; J C Torner; J A Jane; E C Haley; H P Adams
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

5.  Rerupture of coil-embolized aneurysm during long-term observation. Case report.

Authors:  H Manabe; S Fujita; T Hatayama; S Suzuki; S Yagihashi
Journal:  J Neurosurg       Date:  1998-06       Impact factor: 5.115

6.  Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: a prospective study including early operation, intravenous nimodipine, and transcranial Doppler ultrasound.

Authors:  R W Seiler; H J Reulen; P Huber; P Grolimund; U Ebeling; H J Steiger
Journal:  Neurosurgery       Date:  1988-11       Impact factor: 4.654

Review 7.  Selection of cerebral aneurysms for treatment using Guglielmi detachable coils: the preliminary University of Illinois at Chicago experience.

Authors:  G M Debrun; V A Aletich; P Kehrli; M Misra; J I Ausman; F Charbel
Journal:  Neurosurgery       Date:  1998-12       Impact factor: 4.654

8.  A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.

Authors:  J M Findlay; N F Kassell; B K Weir; E C Haley; G Kongable; T Germanson; L Truskowski; W M Alves; R O Holness; N W Knuckey
Journal:  Neurosurgery       Date:  1995-07       Impact factor: 4.654

9.  Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.

Authors:  N F Kassell; E C Haley; C Apperson-Hansen; W M Alves
Journal:  J Neurosurg       Date:  1996-02       Impact factor: 5.115

  9 in total
  1 in total

1.  Coil embolization for intracranial aneurysms: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.